Cargando…
Molecular profiling of tumours for precision oncology – high hopes versus reality
Treatment based on molecular profiling of tumor is advertised however there are very limited clinical data supporting this approach so far. Only one, relatively small, randomized clinical trial (SHIVA) have not met its primary endpoint - prolongation of PFS. Some other unpublished series were report...
Autor principal: | Nawrocki, Sergiusz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5885080/ https://www.ncbi.nlm.nih.gov/pubmed/29628787 http://dx.doi.org/10.5114/wo.2018.73873 |
Ejemplares similares
-
Biomarkers for precision immunotherapy in the metastatic setting: hope or reality?
por: Sajjadi, Elham, et al.
Publicado: (2020) -
High-grade gliomas: reality and hopes
por: Mirimanoff, René-Olivier
Publicado: (2014) -
Hope in the era of precision oncology: a qualitative study of informal caregivers’ experiences
por: Kenny, Katherine, et al.
Publicado: (2023) -
Vaccines: hope vs reality
por: Lawton, Graham
Publicado: (2020) -
3D Tissue and Organ Printing—Hope and Reality
por: Shapira, Assaf, et al.
Publicado: (2021)